Thursday, October 17, 2024

Per feedback from recent trainings, we are hosting a training focused on biomarkers and drug target investigation through effectively utilizing...

Thursday, August 8, 2024

While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data, such...

Thursday, August 8, 2024

There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI), you won't...

Thursday, August 8, 2024

Per feedback from recent trainings, we are hosting a training focused on biomarkers and drug target investigation through effectively utilizing...

Tuesday, July 23, 2024

Per feedback from recent trainings, we are hosting a training focused on biomarkers and drug target investigation through effectively utilizing...

Tuesday, July 23, 2024

There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI), you won't...

Tuesday, June 18, 2024

While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data, such...

Thursday, February 29, 2024

In this webinar, users will learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers, validate targets, and...

Tuesday, September 12, 2023

Cancer outcome is influenced by both the tumor microenvironment and host immune response. Using QIAGEN OmicSoft Studio to access public...

Wednesday, July 12, 2023

In this 90-minute training, you'll learn how to perform drug treatment, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity...

Sample to Insight
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.